These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 22902288

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
    Sachdeo R, Partiot A, Biton V, Rosenfeld WE, Nohria V, Tompson D, DeRossett S, Porter RJ.
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials.
    Gao L, Xia L, Zhao FL, Li SC.
    Epilepsy Res; 2013 Jan; 103(1):31-44. PubMed ID: 22776828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H, Daniluk J, Lotay N, DeRossett S, Edwards S, Brandt C.
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
    Tompson DJ, Crean CS, Reeve R, Berry NS.
    Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
    [Abstract] [Full Text] [Related]

  • 9. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.
    Porter RJ, Burdette DE, Gil-Nagel A, Hall ST, White R, Shaikh S, DeRossett SE.
    Epilepsy Res; 2012 Aug; 101(1-2):103-12. PubMed ID: 22512894
    [Abstract] [Full Text] [Related]

  • 10. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.
    Porter RJ, Partiot A, Sachdeo R, Nohria V, Alves WM, 205 Study Group.
    Neurology; 2007 Apr 10; 68(15):1197-204. PubMed ID: 17420403
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
    Brigo F, Bragazzi NL, Nardone R, Trinka E.
    Seizure; 2016 Nov 10; 42():29-37. PubMed ID: 27710868
    [Abstract] [Full Text] [Related]

  • 12. Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal.
    Craig D, Rice S, Paton F, Fox D, Woolacott N.
    Pharmacoeconomics; 2013 Feb 10; 31(2):101-10. PubMed ID: 23341194
    [Abstract] [Full Text] [Related]

  • 13. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A, Wilke T, Borghs S, Gille P, Joeres L.
    Ger Med Sci; 2017 Feb 10; 15():Doc09. PubMed ID: 28638313
    [Abstract] [Full Text] [Related]

  • 14. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G, Giovannelli F, Maratea D, Fadda V, Verrotti A.
    Seizure; 2013 Sep 10; 22(7):528-36. PubMed ID: 23623245
    [Abstract] [Full Text] [Related]

  • 15. Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.
    Biton V, Gil-Nagel A, Brodie MJ, Derossett SE, Nohria V.
    Epilepsy Res; 2013 Nov 10; 107(1-2):138-45. PubMed ID: 24094693
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
    Slater J, Chung S, Huynh L, Duh MS, Gorin B, McMicken C, Ziemann A, Isojarvi J.
    Epilepsy Res; 2018 Jul 10; 143():120-129. PubMed ID: 29784458
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis.
    Khan N, Shah D, Tongbram V, Verdian L, Hawkins N.
    Curr Med Res Opin; 2013 Aug 10; 29(8):1001-13. PubMed ID: 23659562
    [Abstract] [Full Text] [Related]

  • 18. Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
    Biton V, Rogin JB, Krauss G, Abou-Khalil B, Rocha JF, Moreira J, Gama H, Trinka E, Elger CE, Cheng H, Grinnell T, Blum D, Study 301, 302 and 304 Investigators.
    Epilepsy Behav; 2017 Jul 10; 72():127-134. PubMed ID: 28575761
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
    Gil-Nagel A, Brodie MJ, Leroy R, Cyr T, Hall S, Castiglia M, Twomey C, VanLandingham K.
    Epilepsy Res; 2012 Nov 10; 102(1-2):117-21. PubMed ID: 22771137
    [Abstract] [Full Text] [Related]

  • 20. Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.
    Nass RD, Kurth C, Kull A, Graf W, Kasper B, Hamer HM, Strzelczyk A, Elger CE, Steinhoff BJ, Surges R, Rosenow F.
    Epilepsy Behav; 2016 Mar 10; 56():54-8. PubMed ID: 26828693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.